2024 |
Alkermes plc
|
Executive Vice President, Research and Development and Chief Medical Officer |
4.3 M |
-8.1 % |
2023 |
Alkermes plc
|
Executive Vice President, Research and Development and Chief Medical Officer |
4.7 M |
4.0 % |
2022 |
Alkermes plc
|
Executive Vice President, Research and Development and Chief Medical Officer |
4.5 M |
-3.8 % |
2021 |
Alkermes plc
|
- |
4.7 M |
19.5 % |
2021 |
Alkermes plc
|
Executive Vice President, Research and Development and Chief Medical Officer |
4.7 M |
19.5 % |
2020 |
Alkermes plc
|
- |
4.0 M |
8.2 % |
2020 |
Alkermes plc
|
- |
4.0 M |
8.2 % |
2020 |
Alkermes plc
|
Executive Vice President, Research and Development and Chief Medical Officer |
4.0 M |
8.2 % |
2019 |
Alkermes plc
|
- |
3.7 M |
-3.2 % |
2019 |
Alkermes plc
|
- |
3.7 M |
-3.2 % |
2019 |
Alkermes plc
|
Executive Vice President, Research and Development and Chief Medical Officer |
3.7 M |
-3.2 % |
2018 |
Alkermes plc
|
- |
3.8 M |
- |
2018 |
Alkermes plc
|
Chief Medical Officer and Senior Vice President, Medicines Development and Medical Affairs |
3.8 M |
- |
2018 |
Alkermes plc
|
- |
3.8 M |
- |
2017 |
Alkermes plc
|
Senior Vice President, Medicines Development and Medical Affairs and Chief Medical Officer |
- |
- |